Sarepta Therapeutics
NASDAQ: SRPT
$90.32
+$0.42 (+0.5%)
Closing price January 15, 2021
Friday's top analyst upgrades and downgrades included Aflac, CME, Chevron, CVS Health, D.R. Horton, Goodyear Tire and Rubber, Lam Research, Micron Technology and U.S. Steel.
7 days ago
Last Updated: 7 days ago
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
4 months ago
Last Updated: 4 months ago
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
6 months ago
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
11 months ago
Last Updated: 11 months ago
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
11 months ago
Last Updated: 11 months ago
Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, one analyst sees much more upside for this...
1 year ago
Last Updated: 11 months ago
Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals and Sarpeta Therapeutics.
1 year ago
Last Updated: 11 months ago
Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy.
1 year ago
Last Updated: 11 months ago
Sarepta shares jumped on Friday after the firm announced that the FDA has approved Vyondys 53 (golodirsen) for the treatment of Duchenne muscular dystrophy (DMD) in certain patients.
1 year ago
Last Updated: 11 months ago
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
1 year ago
Last Updated: 11 months ago
Friday's top analyst upgrades, downgrades and initiations included Arista Networks, Booking, Dunkin' Brands, DuPont, GameStop, Generac, PBF Energy, Pinterest, Square and YETI.
1 year ago
Last Updated: 11 months ago
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
1 year ago
Last Updated: 11 months ago
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
1 year ago
Last Updated: 11 months ago
Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall St. has picked a few of those standouts to highlight.
1 year ago
Last Updated: 11 months ago
The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.
1 year ago
Last Updated: 11 months ago